Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating Activities
Net income	$ 43,802	$ 23,376
Depreciation and amortization	9,640	9,326
Stock-based compensation (Note 11)	3,522	2,745
Pension expense (Note 14)	2,216	48
Deferred income tax provision (Note 10)	(546)	1,834
Loss on asset dispositions, net	122	25
Pension contributions (Note 14)	(1,891)	(1,767)
Currency exchange losses, net	270	16,961
Product liability expense (Note 17)	1,951	2,896
Collections on insurance receivables and notes receivable, insurance companies (Note 17)	3,000	8,122
Product liability payments (Note 17)	(2,328)	(20,003)
Changes in:
Trade receivables	(15,339)	(7,720)
Inventories (Note 3)	(18,988)	(16,127)
Prepaid expenses and other current assets	(4,396)	(8,055)
Accounts payable and accrued liabilities	(6,834)	(10,523)
Other noncurrent assets and liabilities	(594)	79
Cash Flow From Operating Activities	13,607	1,217
Investing Activities
Capital expenditures	(6,562)	(4,897)
Purchase of short-term investments (Note 16)	(69,612)	(52,541)
Proceeds from maturities of short-term investments (Note 16)	50,000	33,600
Property disposals	92	12
Cash Flow Used in Investing Activities	(26,082)	(23,826)
Financing Activities
Payments on short-term debt, net	0	91
Proceeds from long-term debt (Note 12)	378,000	133,000
Payments on long-term debt (Note 12)	(350,000)	(119,000)
Cash dividends paid	(16,331)	(14,652)
Company stock purchases (Note 7)	(27,730)	(7,446)
Exercise of stock options (Note 7)	2,733	1,465
Cash Flow Used in Financing Activities	(13,328)	(6,542)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,756)	(3,221)
Decrease in cash, cash equivalents and restricted cash	(29,559)	(32,372)
Beginning cash, cash equivalents and restricted cash	152,543	140,604
Ending cash, cash equivalents and restricted cash	122,984	108,232
Supplemental cash flow information:
Total cash, cash equivalents and restricted cash	$ 122,984	$ 108,232